[Recurrent erysipelas].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D002648:Child; D003604:Czechoslovakia; D004886:Erysipelas / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology / Q000382:microbiology; D005148:Facial Dermatoses / Q000188:drug therapy / Q000453:epidemiology*; D005260:Female; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use; D007279:Injections, Subcutaneous; D007866:Leg; D008297:Male; D008875:Middle Aged; D010406:Penicillins / Q000627:therapeutic use; D013290:Streptococcal Infections / Q000453:epidemiology*; D013291:Streptococcus / Q000302:isolation & purification; D014221:Triamcinolone / Q000627:therapeutic use
D010406:Penicillins; D014221:Triamcinolone; D006821:Hyaluronoglucosaminidase
Rezidivierendes Erysipel.